Implementation of a routine developmental follow-up program for children with congenital heart disease: early results

Cheryl Brosig Soto1, Olubunmi Olude, Raymond G Hoffmann

  • 1Medical College of Wisconsin, Department of Pediatrics Children's Hospital of Wisconsin, Herma Heart Center, 9000 W Wisconsin Avenue, , Milwaukee, WI 53201-1997, USA. cbrosig@chw.org

Insights

Routine developmental follow-up for infants with congenital heart disease is feasible and identifies children needing early intervention. Many infants show lower language and motor scores, highlighting the program

Area of Science:

  • Pediatrics
  • Developmental Pediatrics
  • Pediatric Cardiology

Background:

  • Congenital heart disease (CHD) affects infant development.
  • Early identification of developmental delays is crucial for intervention.
  • A structured follow-up program can aid in this process.

Purpose of the Study:

  • To implement and evaluate a routine developmental follow-up program for infants with CHD.
  • To summarize initial developmental outcomes in this cohort.
  • To identify predictors of early developmental variability.

Main Methods:

  • Infants with CHD at risk for delay were referred to a developmental follow-up program.
  • Developmental assessments were conducted using the Bayley Scales of Infant and Toddler Development-III.
  • Data from 95 infants evaluated before one year of age were analyzed.

Main Results:

  • Language and motor scores were significantly lower than population norms.
  • 44% of infants had at least one low developmental score.
  • Risk factors for poorer outcomes included multiple heart surgeries, comorbidities, and tube feeding.

Conclusions:

  • Routine developmental follow-up for CHD patients is implementable and beneficial.
  • The program effectively identifies children requiring early intervention services.
  • Early identification facilitates timely support for at-risk infants.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...